Kelly Writers House, 3805 Locust Walk
2018 marked 25 years since the University of Pennsylvania Health System (UPHS) was first established—a milestone that would undoubtedly make the institution’s founder, Benjamin Franklin, proud.
An Abramson Cancer Center study identifies a method of priming macrophages to boost an anti-tumor response wherein macrophages attack and eat cancer cells.
A drug approved by the FDA 65 years ago for blood pressure control may aid in preventing cancer from spreading to distant organs. New research led by Serge Fuchs revealed that this drug disrupted formation of a fertile environment for metastasis by protecting healthy cells from harmful vesicles released by tumors.
A study identifies a chain reaction in cells that enables cancer to resist treatments that target BRAF mutations.
Brain tumor patients will now have access to Penn Medicine’s cancer expertise through the new telemedicine second opinion program for brain tumors.
In an update to a global clinical trial stretching from Philadelphia to four continents, the chimeric antigen receptor CAR T cell therapy Kymriah® led to long-lasting remissions in patients with non-Hodgkins lymphoma.
The drug is the first to target common mutations associated with relapse and short survival in acute myeloid leukemia.
The Abramson Cancer Center study is the first to identify what drugs known as chloroquines are targeting when used for cancer treatment.
Penn Medicine experts gathered for a panel discussion about their innovative new approach to harness the body’s own immune system to fight cancer.
Researchers have discovered a way to grow human stem cells destined to become mature sperm in an effort to provide fertility options later in life to males who are diagnosed with cancer and undergo chemotherapy and radiation as children.
Katherine Unger Baillie
Science News Officer
Ezekiel J. Emanuel
Vice Provost for Global Initiatives,
the Diane v.S. Levy and Robert M. Levy University Professor,
and Chair of the Department of Medical Ethics and Health Policy at the University of Pennsylvania. Ezekiel J. Emanuel served as special advisor for health policy to the director of the White House Office of Management and Budget from Jan. 2009 to Jan. 2011. Since 1997 he was chair of the Department of Bioethics at The Clinical Center of the National Institutes of Health and a breast oncologist. Dr. Emanuel received his M.D. from Harvard Medical School and his Ph.D. in political philosophy from Harvard University. After completing his internship and residency in internal medicine at Boston's Beth Israel Hospital and his oncology fellowship at the Dana-Farber Cancer Institute, he joined the faculty at the Dana-Farber Cancer Institute. He has since been a visiting professor at the University of Pittsburgh School of Medicine, UCLA, the Brin Professor at Johns Hopkins Medical School, and the Kovitz Professor at Stanford Medical School and visiting professor at New York University Law School. Dr. Emanuel has written and edited 9 books and over 200 scientific articles. He is currently a columnist for The New York Times.
Virginia A. LiVolsi
Professor of Pathology and Laboratory Medicine, Professor of Surgical Pathology in Surgery Professor of Otorhinolaryngology Head & Neck Surgery.
Director, Office of Strategic Initiatives and Quality Improvement, Anatomic Pathology University of Pennsylvania Perelman School of Medicine.
Perelman School of Medicine.
University of Pennsylvania. Dr. LiVolsi is an expert on the pathology of thyroid cancer. She can speak about thyroid cancers that developed in children and young adults in the years after the 1986 nuclear explosion. She has been involved in the characterization of the pathology of these cancers and has been a member of the international pathology panel for the past 20 years.
Susan Domchek of the Perelman School of Medicine and the Abramson Cancer Center comments on hormonal therapy.
FULL STORY →
Rollin Gallagher of the Perelman School of Medicine comments on a clinical trial that focused on whether acupuncture can relieve pain in cancer patients.
FULL STORY →